IGM Biosciences, Inc.
IGMS
$1.28
$0.064.92%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 40.34% | -28.24% | 3.84% | 17.92% | 2.09% |
| Total Depreciation and Amortization | 1.99% | 1.36% | 4.60% | -0.23% | -3.45% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -63.22% | 87.31% | 11.47% | -26.39% | -25.00% |
| Change in Net Operating Assets | -289.51% | 502.12% | 69.97% | -364.07% | -113.56% |
| Cash from Operations | 9.29% | -2.71% | 11.89% | 11.65% | -19.66% |
| Capital Expenditure | 33.28% | -6.43% | 51.13% | -71.55% | 53.03% |
| Sale of Property, Plant, and Equipment | -100.00% | -78.13% | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 32.15% | -44.48% | 130.86% | 184.07% | -158.52% |
| Cash from Investing | 38.59% | -47.05% | 183.48% | 158.88% | -175.16% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -65.03% | 85.63% | 236.98% | -52.24% | -99.10% |
| Repurchase of Common Stock | -- | 100.00% | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 100.00% | 22.50% | -- | -- |
| Cash from Financing | -65.03% | 95.28% | 304.61% | -62.19% | -99.10% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 32.21% | -97.78% | 63.60% | 46.04% | -358.86% |